CD133-high ER+/HER2− BC was associated with CD24, NOTCH1, DLL1, and ALDH1A1 gene expressions, as well as with WNT/β-Catenin, Hedgehog, and Notchsignaling pathways, all characteristic for CSC. The gene discussed is NOTCH1; the disease is breast cancer.